On 22.07.2019 ECHA published a Guidance Document on “harmonised information relating to emergency health response – Annex VIII to CLP“.
On 01.07.2019 ECHA initiated a consultation on the CLH report for piperonyl butoxide.
On 01.07.2019 ECHA initiated a public consultation on the CLH report on dimoxystrobin.
On 27.06.2019 ECHA published the agenda for the RAC 50 meeting, scheduled for 9-13 September 2019 and 16-20 September 2019.
On 17.06.2019 ECHA initiated the public consultation on the classification of quinoclamine.
On 27.05.2019 ECHA opened a public consultation on the CLH report for isoflucypram.
On 18.03.2019 ECHA initiated the public consultation for the classification of 4 substances.
On 17.12.2018 ECHA initiated public consultations on the classification proposals for esfenvalerate, ethametsulfuron-methyl and trifloxystrobin.
ECHA published on 05.12.2018 a short report on the RAC 47 meeting.
On 03.12.2018 ECHA initiated a public consultation on the classification proposals for triticonazole, desmedipham and phenmedipham.
On 26.11.2018 ECHA started a consultation on the CLH report for clomazone, submitted by RMS Denmark.
On 12.11.2018 ECHA published the minutes of the RAC-46 meeting.
On 02.11.2018 Slovenia submitted a CLH report for accordance check.
On 29.10.2018 ECHA initiated a public consultation on the CLH report for substance.
On 29.10.2018 ECHA initiated a public consultation on the CLH report for trinexapac-ethyl.
On 29.10.2018 ECHA initiated a public consultation on the CLH report for S-abscisic acid.
On 08.10.2018 ECHA initiated a public consultation on the CLH report for diflufenican.
On 08.10.2018 ECHA initiated a public consultation on the CLH report for mecoprop-p.
On 08.10.2018 ECHA initiated a public consultation on the CLH report for imidacloprid.
On 24.09.2018 a Commission Notice was published in the Official Journal on the availability and applicability of the EFSA guidance on endocrine properties.